CIK 0002007919
- Emerging growth company
Inhibrx Biosciences, Inc.
Sign in to watch- Ticker
- INBX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 990613523
- Phone
- +1 858-795-4220
- Business address
- 11025 N. TORREY PINES ROAD, SUITE 140, LA JOLLA, CA, 92037
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Gift Director gave 90,000 shares (gift)
- 4 Gift Director gave 500,000 shares (gift)
- 4 Gift Director gave 52,000 shares (gift)
- 4 Open-market buy Director bought 107,186 shares at an average $14.21 ($1,523,620)
- 4 Open-market buy Director bought 6,667 shares at $15.00 ($100,005)
- 4 Open-market buy Chief Executive Officer bought 40,000 shares at an average $15.73 ($629,117)
- 4 Open-market buy Director bought 6,636 shares at an average $15.07 ($99,992)
- 4 Open-market buy Chief Executive Officer bought 44,000 shares at an average $15.25 ($671,150)
- 4 Open-market buy Chief Executive Officer bought 40,000 shares at an average $14.92 ($596,763)
- 4 Open-market buy Director bought 7,140 shares at $14.00 ($99,960)
- 4 Open-market buy Director bought 10,000 shares at $13.98 ($139,800)
- 4 Open-market buy Director bought 75,000 shares at an average $13.83 ($1,037,328)
- 4 Open-market buy Chief Executive Officer bought 40,000 shares at an average $12.96 ($518,282)
- 4 Gift Director gave 89,050 shares (gift)
Page 2 of 3 · 59 filings